In studies on HCC and to a somewhat lesser extent, iCCA, the contributions of ANG-2 and the VEGF to the advancement of these cancers have been thoroughly documented through analysis of patient samples, including serum and tissue biopsies. The gene discussed is VEGFA; the disease is cancer.